Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Avax evaluates its ovarian cancer vaccine in phase II

Oct. 20, 1997

New GVAX cancer vaccine begins human testing

Oct. 17, 1997

Jenner Technologies initiates clinical testing of AdjuVax-100a

Oct. 16, 1997

Meeting of Biological Response Modifiers Advisory Committee this week

Oct. 14, 1997

Cancer cells being used to treat cancer

Oct. 13, 1997

Phase II results for IDEC-C2B8 in NHL

Oct. 13, 1997

Preliminary results from study of MultiKine in head and neck cancer patients

Oct. 9, 1997

Genentech returns rights to IDEC-Y2B8 to IDEC

Oct. 6, 1997

IL-2 + IFN-alpha in phase II for renal cell carcinoma

Oct. 1, 1997

Techniclone submits IND for malignant glioma

Sep. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...